PXMD

PaxMedica, Inc. Common Stock PXMD

PXMD
PaxMedica, Inc. Common Stock VRAX
Virax Biolabs Group Limited REVB
Revelation Biosciences, Inc. QNRX
Quoin Pharmaceuticals, Ltd. CDIO
Cardio Diagnostics Holdings, Inc. BIAF
bioAffinity Technologies, Inc. SHPH
Shuttle Pharmaceuticals Holdings, Inc. ILAG
Intelligent Living Application Group Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PXMD VRAX REVB QNRX CDIO BIAF SHPH ILAG
6M -50.00 % -42.04 % -85.85 % 195.90 % -65.27 % -83.64 % -60.11 % 69.66 %
YTD -99.85 % -70.89 % -95.72 % 2 266.34 % -83.91 % -90.60 % -82.85 % -33.24 %
1Y -99.92 % -64.45 % -96.44 % 3 015.69 % -33.23 % -95.28 % -88.03 % -41.62 %
3Y -100.00 % -96.32 % -99.99 % -22.11 % -98.60 % -96.68 % -99.43 % -88.68 %
5Y -100.00 % -99.65 % -100.00 % -98.80 % -98.57 % -98.94 % -99.95 % -90.27 %
10Y -100.00 % -99.65 % -100.00 % -99.90 % -98.57 % -98.94 % -99.95 % -90.27 %
From the beginning -100.00 % -99.65 % -100.00 % -99.90 % -98.57 % -98.94 % -99.95 % -90.27 %

Dividend